A combinational chemo-immune therapy using an enzyme-sensitive nanoplatform for dual-drug delivery to specific sites by cascade targeting
Open Access
- 5 February 2021
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 7 (6), eaba0776
- https://doi.org/10.1126/sciadv.aba0776
Abstract
Nanoparticulate-based combinatorial therapy induced robust antitumor immunity against tumor metastasis.Funding Information
- National Natural Science Foundation of China (51973135)
- National Key Research and Development Program of China Stem Cell and Translational Research (2018YFC1106103)
This publication has 40 references indexed in Scilit:
- Doxorubicin, DNA torsion, and chromatin dynamicsBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2014
- Doxorubicin Eliminates Myeloid-Derived Suppressor Cells and Enhances the Efficacy of Adoptive T-Cell Transfer in Breast CancerCancer Research, 2014
- The blockade of immune checkpoints in cancer immunotherapyNature Reviews Cancer, 2012
- Mitochondrial targeting liposomes incorporating daunorubicin and quinacrine for treatment of relapsed breast cancer arising from cancer stem cellsBiomaterials, 2012
- Cancer nanotechnology: application of nanotechnology in cancer therapyDrug Discovery Today, 2010
- Immunogenic Tumor Cell Death for Optimal Anticancer Therapy: The Calreticulin Exposure PathwayClinical Cancer Research, 2010
- PD-1 and Its Ligands in Tolerance and ImmunityAnnual Review of Immunology, 2008
- Immunological aspects of cancer chemotherapyNature Reviews Immunology, 2008
- Immunosuppressive networks in the tumour environment and their therapeutic relevanceNature Reviews Cancer, 2005
- Mechanism of apoptosis induced by doxorubicin through the generation of hydrogen peroxideLife Sciences, 2005